Barnett Rick
Known title: DirectorCIK: 0001949746
Associated companies
Transaction History
| ICU | ▲ Buy | Grant | 70,264 | $0 | 4/12/2024 | View on chart |
| ICU | ▲ Buy | Grant | 7,978 | $0 | 4/6/2023 | View on chart |
| ICU | ▲ Buy | Grant | 8,422 | $0 | 10/28/2022 | View on chart |
| ICU | ▲ Buy | Grant | 70,264 | $0 | 4/12/2024 | View on chart |
| ICU | ▲ Buy | Grant | 7,978 | $0 | 4/6/2023 | View on chart |
| ICU | ▲ Buy | Grant | 8,422 | $0 | 10/28/2022 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
SeaStar Medical Adds ICD‑10‑PCS Codes for AKI Therapy
SeaStar Medical has released new ICD‑10‑PCS codes for its SCD therapy used in acute kidney injury. The codes allow hospitals to bill for the treatment, which could broaden usage. Earlier this week the company’s Chief Medical Officer, Kevin Chung, will speak at the Pediatric Paracorporeal and Extracorporeal Therapy Symposium, highlighting the therapy’s pediatric applications. The company’s shares are trading near a key support level and have shown a recent volume spike.
SeaStar Medical Adds ICD‑10‑PCS Codes for AKI Therapy. SeaStar Medical has released new ICD‑10‑PCS codes for its SCD therapy used in acute kidney injury. The codes allow hospitals to bill for the treatment, which could broaden usage. Earlier this week the company’s Chief Medical Officer, Kevin Chung, will speak at the Pediatric Paracorporeal and Extracorporeal Therapy Symposium, highlighting the therapy’s pediatric applications. The company’s shares are trading near a key support level and have shown a recent volume spike.